DARZALEX SC sol inj 1800 mg/15ml flac 15 ml
7680676890018
CH-67689
L01FC01
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6768901
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- daratumumabum 1800 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, sorbitolum 735.1 mg, methioninum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 15 ml.
Articles (1)
DARZALEX SC 1800 mg/15 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
daratumumabum
|
1800.0 MG | Substance | Wirkstoff (Principe actif) |
|
hyaluronidasum humanum ADNr
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
sorbitolum
|
735.1 MG | Substance | HBESI |
|
methioninum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4932.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2020
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 67689
- Drug name
- DARZALEX SC, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01FC01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/08/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DARZALEX SC sol inj 1800 mg/15ml flac 15 ml
- Description (DE)
- DARZALEX SC Inj Lös 1800 mg/15ml Durchstf 15 ml
- Market launch
- 07/09/2020
- Narcotic (BTM)
- No